Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Smart Drug Delivery Systems Market from 2024 to 2025?
The market size for smart drug delivery systems has seen a significant growth in the past few years. The market, which is anticipated to be $12.65 billion in 2024, is projected to escalate to $15.17 billion in 2025, representing a compound annual growth rate (CAGR) of 19.9%. The surge in growth during the past years can be credited to factors such as heightened demand for drug delivery systems, increasing patient adherence, rising prevalence of chronic illnesses, growth in the field of personalized medicine, and the necessity for cost-effective healthcare solutions.
What Is the Projected Market Size of the Smart Drug Delivery Systems Market?
In the coming years, the market for smart drug delivery systems is predicted to experience a swift expansion. It is projected to reach $31.01 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 19.6%. The predicted upswing can be attributed to a variety of factors, including the escalating concern of non-communicable diseases, an increased emphasis on precision medicine, the emergence of theragnostic, a rising demand for non-invasive drug delivery techniques, and expanding healthcare spending. Important trends expected during this forecast period encompass miniaturization and microfabrication technologies, progress in material science, the incorporation of artificial intelligence (AI) and machine learning (ML), the emergence of nano-sized drug delivery systems, and the integration of IoT and wearable technology.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14796&type=smp
Who are the Major Competitors in the Smart Drug Delivery Systems Market Outlook?
Major companies operating in the smart drug delivery systems market are Pfizer Inc., Johnson & Johnson, Bayer AG, Abbott Laboratories, Novartis International AG, Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk, Merck Group, Becton Dickinson and Company, Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, Biogen Inc., Vertex Pharmaceuticals Incorporated, Phillips-Medisize Corporation, ResMed Inc., West Pharmaceutical Services Inc., Insulet Corporation, Owen Mumford Ltd., Sonceboz, H&T Presspart Manufacturing Ltd., E3D Elcam Drug Delivery Devices, CeQur Corporation
What Is Fueling Growth in the Smart Drug Delivery Systems Market?
The surge in chronic diseases is anticipated to drive the growth of the smart drug delivery systems market. Chronic illnesses are long-term health issues that gradually worsen over time and usually have multifaceted origins. The rise in chronic diseases is due in part to older populations, environmental effects, and inequalities in healthcare accessibility. Smart drug delivery systems provide a viable solution for managing chronic diseases by improving the efficacy of medications and boosting patient compliance. For example, the National Library of Medicine reported in January 2023 that by 2050, the number of people suffering from at least one chronic disease will reach 142.66 million, representing a 99.5% increase from 71.522 million in 2020. Consequently, the burgeoning occurrence of chronic diseases is fueling the smart drug delivery systems market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=14796&type=smp
Which Smart Drug Delivery Systems Market Segments Are Growing the Fastest?
The smart drug delivery systems market covered in this report is segmented –
1) By Product: Connected Inhalers, Connected Autoinjectors, Connected Pen Injectors, Connected Wearable Injectors, Add-On Sensors, Other Products
2) By Therapeutic Area: Metabolic Disorders, Neurological Disorders, Respiratory Disorders, Hormonal Disorders, Other Therapeutic Areas
3) By Drug Delivery Mode: Injectable, Inhalation, Oral
4) By End-User: Hospitals, Clinics, Home Care, Ambulatory Care Settings, Other End-Users
Subsegments:
1) By Connected Inhalers: Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs)
2) By Connected Autoinjectors: Single-Dose Autoinjectors, Multi-Dose Autoinjectors
3) By Connected Pen Injectors: Insulin Pen Injectors, Biologic Pen Injectors
4) By Connected Wearable Injectors: Insulin Wearable Injectors, Infusion Pump Wearable Injectors
5) By Add-On Sensors: Glucose Monitoring Sensors, Medication Adherence Sensors, Temperature Sensors
6) By Other Products: Smart Syringes, Smart Patches, Smart Implants
Which Industry Trends Are Shaping the Future of the Smart Drug Delivery Systems Market?
Prominent organizations in the smart drug delivery systems market are concentrating on the fabrication of recyclable medication dispensing devices, similar to Qfinity, with the aim of transforming drug administration practices. Qfinity differs from disposable, single-use items as it purports to be reusable after medication dispersal. For example, in May 2022, Jabil Inc., an American manufacturing services firm, introduced Qfinity, a recyclable drug dispensing device specifically designed for subcutaneous drug self-administration. The device has a capacity of over 100 injections per apparatus and can accommodate 1 mL or 2.25 mL pre-filled cartridges, leading to a decrease of 60% in carbon emissions per injection. The Qfinity autoinjector platform is flexible, with a wide range of technical specifications for drug volumes and viscosities. Furthermore, a connected variant referred to as Qfinity+ enables remote patient monitoring and adherence through integrated sensors and electronics, ensuring connectivity without sacrificing user-friendliness.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/smart-drug-delivery-systems-global-market-report
Which Countries Are Leading the Smart Drug Delivery Systems Market?
North America was the largest region in the smart drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14796
This Report Delivers Insight On:
1. How big is the smart drug delivery systems market, and how is it changing globally?
2. Who are the major companies in the smart drug delivery systems market, and how are they performing?
3. What are the key opportunities and risks in the smart drug delivery systems market right now?
4. Which products or customer segments are growing the most in the smart drug delivery systems market?
5. What factors are helping or slowing down the growth of the smart drug delivery systems market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model